Stonepine Capital Management’s Nektar Therapeutics NKTR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$1.3M	Buy	+50,200	New	+$1.3M	1.27%	20
2024 Q2	–	Sell	-232,027	Closed	-$3.25M	–	28
2024 Q1	$3.25M	Buy	+232,027	New	+$3.25M	2.58%	8